Ó£»¨ÊÓƵ

Skip to main content

Table 4 Subgroup analyses between the association of CDAI and BPH

From: Possible impact of antioxidant intake on composite dietary antioxidant index and the progression of benign prostatic hyperplasia: an observational study

Subgroups

OR (95%CI)

P value

P for interaction

Age

ÌýÌý

0.783

&±ô³Ù; 60

1.051(1.000,1.104)

0.051

Ìý

>=60

1.042(1.004,1.080)

0.029

Ìý

alcohol user

ÌýÌý

0.086

never

1.066(0.954, 1.191)

0.255

Ìý

former

1.042(0.986,1.100)

0.139

Ìý

mild

1.062(1.020,1.105)

0.004

Ìý

heavy

0.983(0.922,1.049)

0.603

Ìý

smoke

ÌýÌý

0.965

never

1.038(0.989,1.089)

0.128

Ìý

former

1.060(1.021,1.101)

0.003

Ìý

current

1.027(0.979, 1.078)

0.275

Ìý

BMI

ÌýÌý

0.896

&±ô³Ù; 25

1.033(0.971, 1.100)

0.299

Ìý

25–30

1.042(0.996,1.089)

0.074

Ìý

>=30

1.050(1.011,1.090)

0.012

Ìý

hypertension

ÌýÌý

0.707

no

1.048(1.002,1.095)

0.040

Ìý

yes

1.042(1.004,1.082)

0.030

Ìý

DM

ÌýÌý

0.59

no

1.048(1.014,1.083)

0.006

Ìý

yes

1.046(0.989,1.106)

0.114

Ìý

CVD

ÌýÌý

0.062

no

1.058(1.022,1.096)

0.002

Ìý

yes

0.994(0.937,1.054)

0.838

Ìý
  1. OR: odds ratio; BMI: body mass index; BPH: benign prostatic hyperplasia; CVD: cardiovascular disease; DM: diabetes mellitus
  2. The CDAI was seen as a continuous variable. A P for interaction > 0.05 indicated that the subgroup was meaningless